Memorial Sloan Kettering Cancer Center’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,128,255
| Closed | -$44M | – | 6 |
|
|
2022
Q1 | $44M | Sell |
1,128,255
-1,552,389
| -58% | -$60.5M | 50.9% | 1 |
|
|
2021
Q4 | $107M | Hold |
2,680,644
| – | – | 67.12% | 1 |
|
|
2021
Q3 | $96.9M | Hold |
2,680,644
| – | – | 60.36% | 1 |
|
|
2021
Q2 | $110M | Hold |
2,680,644
| – | – | 71.84% | 1 |
|
|
2021
Q1 | $117M | Sell |
2,680,644
-885,243
| -25% | -$38.6M | 72.07% | 1 |
|
|
2020
Q4 | $178M | Buy |
+3,565,887
| New | +$178M | 75.56% | 1 |
|